Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonismNUENEN, Bart F. L. Van; HELMICH, Rick C; VAN DE WARRENBURG, Bart P. C et al.Brain. 2012, Vol 135, pp 3687-3698, issn 0006-8950, 12 p., 12Article

Lower cognitive performance in healthy G₂019S LRRK2 mutation carriersTHALER, Avner; MIRELMAN, Anat; GUREVICH, Tanya et al.Neurology. 2012, Vol 79, Num 10, pp 1027-1032, issn 0028-3878, 6 p.Article

Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersTHALER, Avner; MIRELMAN, Anat; GILADI, Nir et al.Cortex (Testo stampato). 2013, Vol 49, Num 9, pp 2501-2511, issn 0010-9452, 11 p.Article

Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's diseaseGILADI, Nir; MIRELMAN, Anat; THALER, Avner et al.Journal of the neurological sciences. 2011, Vol 310, Num 1-2, pp 17-20, issn 0022-510X, 4 p.Article